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ABSTRACT 
 Cervical cancer has a major impact on women’s lives especially in developing countries 
where it is the leading cause of death due to late presentation. Cervical cancer usually 
remains asymptomatic in the pre invasive and early stages until the disease is locally 
advanced. The treatment for cervical cancer is guided by the age and general health of the 
patient as well as the extent of the cancer and presence or nature of any complicating 
abnormalities. Radiotherapy is the major treatment modality for cervical cancer and 
approximately 60% of patients with cervical cancer receive radiotherapy at some point during 
the treatment of the disease.  Cervical cancer and its treatment can result in physical, 
psychological and sex-related effects.  
Research problem, question and purpose: Little is known concerning cervical cancer 
treatment related effects South African women experience 12 months after completing 
treatment as no literature exploring this subject could be found. The research question is 
therefore: What long term effects do women treated for cervical cancer at an academic 
hospital in Johannesburg experience 12 months after completion of treatment? The purpose 
of the study is to explore the effects women experience after 12 months of treatment for 
cervical cancer with radiotherapy. 
Design: A qualitative method and descriptive phenomenological design was used for this 
study. The setting was the Department of Radiation Oncology at an academic hospital in 
Johannesburg. The population comprised all women diagnosed with cervical cancer who 
completed radiotherapy treatment 12 months prior the study. Purposive sampling was used 
and the sample totalled 16 (n=16). Data were collected using open-ended, unstructured 
interviews.  
Findings: The responses elicited from the interviews, women experience problems related to 
Physical, Social-economic. Psycho-spiritual and sexual problems of being treated for cervical 
cancer.  
Conclusion: Women experience physical problems which has an impact on their social-
economical, psycho-spiritual and sexual lives as a result of long-term effects of cervical 
cancer and its treatment 
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CHAPTER 1 
OVERVIEW FOR THE STUDY 
1.1 INTRODUCTION 
This chapter presents an overview of the study and includes the background to the study, the 
problem statement, the purpose, the significance and relevant definitions. An overview of the 
research method is also provided, as well as a description of the measures to ensure trustworthiness 
and ethical considerations. 
1.2 BACKGROUND OF THE STUDY  
Cancer is a global public health problem, the second most common cause of death in the developed 
world and one of the three leading causes of death in the adult population in developing countries. 
Cancer is responsible for 12.6% of all deaths, which is more than the combination of deaths caused 
by HIV and AIDS, malaria and tuberculosis (World Health Organization and International Union 
against Cancer, 2005).   
Cervical cancer, after breast cancer, is the second most common cancer in women globally (World 
Health Organization, 2010) and approximately 500 000 women are newly diagnosed annually. 
More than 85% newly diagnosed women live in developing countries where cervical cancer 
accounts for 13% of all female cancers (Ferlay et al., 2010). In Africa, with a population of 267.9 
million women aged 15 years and above, it is estimated that 78 897 women are diagnosed with 
cervical cancer annually and 61 671 (78%) will die from the disease (Ashford & Collymore, 2005) 
as women present with advanced disease (Denny, 2010).The exact number of South African 
women diagnosed with cervical cancer is not clear due to the pathological based cancer registry not 
being maintained (Denny, 2010) and underreporting (Albrecht, 2006). However, the 2005 Cancer 
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Registry (National Health Laboratory Service, 2012) indicates that cervical cancer was responsible 
for 17.76% of all female cancers reported during that year.   
Treatment for cervical cancer varies according to the stage of the disease and includes cryotherapy 
for preinvasive disease, surgery for early stages and radiotherapy with or without chemotherapy for 
invasive disease (Itano & Taoka, 2005). Radiotherapy causes both acute and late effects. Acute 
effects are those experienced during and immediately after radiotherapy, whilst late effects can 
develop months to years after treatment (Faithful, 2006). Physical effects resulting from 
radiotherapy include diarrhoea, constipation, lymphedema, menopausal symptoms, poor body 
image, sexual and or vaginal disfunctioning, dyspareunia  (Park, Bae & Nam, 2007) and chronic 
fatigue  (Vistad, Fossa, Kristensen & Dahl, 2007). These physical effects have an impact on the 
emotional, psychosocial and sexual life (Saewong & Choobum, 2005; Korfage et al., 2009), thus 
affecting the performance of housework, paid employment and social activity, which could be 
attributed mainly to physical problems women experience (Vistad et al., 2006).   
 1.3 PROBLEM STATEMENT AND RESEARCH QUESTION   
Literature is a guide to what the long-term effects of radiotherapy for cervical cancer are. However, 
it is not known how women experience these effects as no literature describing this issue could be 
found.  The research question for the study is therefore: How do women diagnosed with cervical 
cancer and treated with radiotherapy at an academic hospital in Johannesburg, experience the long-
term effects of the disease and treatment? 
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1.4 PURPOSE OF THE STUDY 
The purpose of the study was to explore how women diagnosed with cervical cancer and treated 
with radiotherapy at an academic hospital in Johannesburg, experience the long-term effects of the 
disease and treatment.  
1.5 SIGNIFICANCE OF THE STUDY 
This study was conducted to investigate which of the known late effects of the treatment of 
cervical cancer are problematic to women and how they experience them. Knowledge of these 
experiences will enable nurses to reflect on the supportive care provided to these patients and 
determine whether the identified problems are managed and how to improve the management 
thereof. This will also help assess and manage these problems adequately and measures can be put 
in place where possible before, during and after treatment to prevent some of the problems that will 
be identified.  
1.6 OPERATIONAL DEFINITIONS 
 
Cervical cancer 
Cancer that affects the uterine cervix; the uterine cervix is the neck of the uterus in women 
(Brooker, 2006). 
 
Late effects 
For the purpose of this study, late effects refer to the cancer and treatment related complications 
that women experience 12 months after completing radiotherapy.  
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Radiotherapy 
Radiotherapy refers to the use of ionizing radiation in the treatment of patients with benign and 
malignant diseases (Otto, 2007). 
 
1.7  RESEARCH METHODS  
A qualitative method (Begley, 2008) and descriptive phenomenological design (McCance & 
Mcilfatric, 2008) was used for this study. The setting was the Department of Radiation Oncology at 
an academic hospital in Johannesburg. The population comprised all women diagnosed with 
cervical cancer who completed radiotherapy treatment 12 months prior the study. Purposive 
sampling (McCance & Mcilfatric, 2008) was used in order to obtain greater richness of data for the 
study. All women recruited for the study were willing to participate and the sample totalled 16 
(n=16). Data were collected using in-depth interviews. An interview guide (Appendix D) directed 
the collection of general information whereafter one question was posed to participants. Probes 
were used to increase detailed explorations (Appendix D). The interview guide was pre-tested 
using the first participant. The data were analysed using the Colaizzi method as described by Polit 
and Beck (2012). The use of Lincoln and Guba’s framework (Guba & Lincoln, 1995 in Polit & 
Beck, 2012) was to enhance the trustworthiness of the findings. The ethical guidelines outlined in 
the Belmont Report (Polit & Beck, 2012) applied to the study. 
1.8 OUTLINE OF THE STUDY 
This study will be presented as follows: 
Chapter 1: Overview of the study 
Chapter 2: Literature review  
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Chapter 3: Research methods 
Chapter 4: Findings and discussion 
Chapter 4: Limitations, recommendations and conclusion 
1.9 SUMMARY 
This chapter introduced the reader to the study. The problem statement, research question and the 
purpose have been stated. In addition, an overview of the research methods including the plan of 
research action has been provided. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1 INTRODUCTION 
In the previous chapter, an overview of the study was provided. This chapter provides a literature 
review in order to enhance the reader’s understanding of cervical cancer and its treatment. 
2.2 INCIDENCE OF CERVICAL CANCER 
According to the World Health Organization (2010), cervical cancer is the second most common 
cancer in women globally. More than 85% of the global burden occurs in developing countries, 
where it accounts for 13% of all female cancers (Ferlay, Shin & Bray et al., 2010). There are 
approximately 500 000 women newly diagnosed with cervical cancer annually worldwide, 
resulting in a 50% mortality largely due to late presentation and lack of treatment facilities 
(Moodley, 2009). According to Ashford and Collymore (2005), cervical cancer has a major impact 
on women’s lives especially in developing countries where it is the leading cause of death in 
women. In developing countries, approximately 493,000 women are newly diagnosed each year 
and approximately 274,000 die from this disease mainly because screening programmes are not 
well established.  
Over 80% of women newly diagnosed with cervical cancer live in developing countries and most 
of them are diagnosed when the disease is advanced (World Health Organisation (WHO), 2006). In 
Africa, with the population of 267.9 million women aged 15 years and above, it is estimated that 
78 897 women are diagnosed with cervical cancer annually whilst 61 671 (78%) will die from the 
disease (Ashford & Collymore, 2005). Cervical cancer is not only a common cancer amongst poor 
women, but cure rates are low because they present with advanced disease (Denny, 2010).The 
exact number of South African women diagnosed with cervical cancer is not clear due to the 
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pathological based cancer registry not being maintained (Denny, 2010) and underreporting 
(Albrecht, 2006). However, the 2005 Cancer Registry (National Health Laboratory Service, 2012) 
indicates cervical cancer was responsible for 17.76% of all cancers occurring in women reported 
during that year.   
2.3 RISK FACTORS 
According to the WHO (2006), the primary underlying cause of cervical cancer is infection with 
human papillomavirus (HPV), a very common virus transmitted sexually. Even though HPV is the 
most important risk factor, epidemiologic studies have identified several other factors, a finding 
that helps explain why HPV infections resolve spontaneously in some women and progress to 
invasive cancer in others (Varricchio, 2004). There are more than 40 mucosal HPV types, which 
can infect the lower genital tract in human beings and approximately 15 of these types are 
associated with carcinogenesis. HPV 16 and 18 are the two high-risk viruses responsible for 
approximately 70% of all cervical cancers worldwide and also responsible for the vast majority of 
cervical cancers in Africa, as well as South Africa (Snyman, 2013). 
Various co-factors have been identified which, according to the World Health Organization (2006) 
are:  
 low immune status and HIV infection therefore increases the risk; 
 high parity; 
 tobacco smoking; 
 co-infection with HIV or other sexually transmitted agents such as Herpes Simplex Virus 2, 
Chlamydia trachomatis and Neisseria gonorrhoea; 
 long-term, more than 5 years,  use of oral contraceptives;  
 vitamin deficiencies. 
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2.4 PREVENTION OF CERVICAL CANCER   
Cervical cancer has a natural history and it usually takes 10 to 20 years for precursor lesions caused 
by HPV to develop into invasive disease (WHO, 2006). Cervical cancer is preceded by a 
preinvasive condition known as intraepithelial lesion or cervical intraepithelial neoplasia 
(Varricchio, 2004). Cellular changes taking place range from premalignant changes that is; mild to 
moderate to severe cervical intraepithelial neoplasia (CIN), to carcinoma in situ (CIS), to invasive 
disease (Itano & Taoka, 2005). Carcinoma in situ and pre-invasive forms are curable; at the onset 
of the disease, cellular growth is slow but once it is invasive, it grows rapidly. Therefore, the 
prolonged natural history of the disease makes it ideal for screening interventions (Varricchio, 
2004). This also means that most cervical cancers can be prevented by early detection and 
treatment of precancerous lesions (WHO, 2006). 
2.4.1 Primary Prevention 
Primary prevention of cervical cancer refers to the prevention of HPV infection and co-factors 
known to increase the risk of cervical cancer (WHO, 2006) or at least preventing  persistent 
infection of the cervix with HPV (Denny, 2010) and include: 
 education and awareness on the need to reduce high risk sexual behaviours, abstinence, 
having one faithful sexual partner and the use of condoms; 
 the development and introduction of effective and affordable HPV vaccines; 
 efforts to discourage tobacco use. 
2.4.2 Secondary Prevention 
Secondary prevention of cervical cancer relies on the detection of cervical cancer precursors and 
the removal of the transformation by either excision or ablation (Denny, 2010). This is achieved 
through screening which aims at detecting precancerous changes, which if not treated may lead to 
cancer. Early detection according to the WHO, (2006) includes: 
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 organised screening programmes, targeting the appropriate age groups and with effective 
links between all levels of care; 
 education for healthcare providers and women in the target group on benefits of screening, 
age at which cervical cancer most commonly occurs and also signs and symptoms; 
 follow-up of patients who are positive on screening, to ensure a diagnosis is made and the 
disease is appropriately managed;  
 treatment of precancer, using relatively simple procedures to prevent the development of 
cancer. 
2.4.3 Screening tests currently available.  
According to the WHO (2006), cervical cancer screening tests available include: 
 Cytology-based: Conventional (Pap smear) and liquid based, this requires highly trained 
personnel, well equipped laboratories, transport of specimens and an effective system for 
collecting information and following up patients. 
 Visual inspection with acetic acid (VIA) or Lugol’s iodine (VILI), has shown promise in 
controlled research settings but not widely implemented. Promising alternatives to cytology 
where resources are limited. Results are available immediately eliminating the need for 
multiple visits in most cases and reducing loss to follow-up. 
 HPV-DNA Tests are also commercially available but the disadvantages include the need 
for sophisticated laboratory facilities and high cost 
2.4.4 Prevention of cervical cancer in South Africa 
The most powerful tool to date for prevention of cervical cancer has been the implementation of 
national, organised mass cytology-base screening programmes, because where this has been 
successful, the incidence of cervical cancer has been reduced dramatically. In 2000, South Africa 
10 
 
implemented a cervical cancer screening policy expecting to reduce the cumulative incidence of 
cervical cancer by approximately two-thirds (Denny, 2010). The national policy supports primary 
and secondary prevention and targets women 30 years and older. Women, no younger than 30 
years, are offered three (3) free smears with a 10 years interval in between each smear. Those 
screened for first time at the age of 55 or more will have only one smear if first smear is normal.  
Women with low-grade squamous intraepithelial lesions require re-screening in 12 months’ time, 
whilst those with high-grade lesions should be referred for colposcopy. 
However, there has been a low screening uptake in South Africa despite the national screening 
policy, as the policy has not been formally implemented countrywide. It is estimated that screening 
coverage is mainly done on an opportunistic basis, with the uptake as low as 13% (Snyman, 2013).  
2.5 SIGNS AND SYMPTOMS OF CERVICAL CANCER 
Cervical cancer usually remains asymptomatic in the preinvasive and early stages until the disease 
is locally advanced (WHO, 2006; Otto, 2007). The early signs of disease include a thin, watery 
discharge that usually is blood tinged, but as it progresses, the patient has frequent episodes of 
bleeding (Varricchio, 2004). The episodes of bleeding include abnormal vaginal bleeding which 
could be postcoital, intermenstrual or post-menopausal or an increase in length and amount of 
menstrual flow and a watery serosanguineous vaginal discharge. Late symptoms may include 
dysuria, urinary retention, haematuria and hydronephrosis and also bowel symptoms such as rectal 
bleeding, bowel obstruction and constipation, which suggest tumour invasion of the bladder or the 
rectum. Edema to the lower extremities maybe as a result of lymphatic obstruction, pelvic or sciatic 
pain suggests nerve involvement (Otto, 2007). 
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2.6 DIAGNOSIS OF CERVICAL CANCER 
2.6.1 Diagnosis and Management of Precancerous Lesions 
Further investigations are needed with a positive or abnormal screening test, in order to make a 
definitive diagnosis and the standard method for diagnosis of cervical precancerous lesions is 
histopathological examination of tissue obtained through biopsy guided by colposcopy. 
Precancerous lesions are treated by means of cryotherapy and loop electrosurgical excision 
procedure (LEEP); cold knife conisation is appropriate when the eligibility criteria for cryotherapy 
and LEEP are not met, but hysterectomy should not be used to treat precancer unless there are 
other compelling reasons to remove the uterus (WHO, 2006). 
2.6.2 Diagnosis of Cervical Cancer 
Cervical biopsy, when abnormalities are identified, confirms the diagnosis of cancer (Itano & 
Taoka, 2005). For invasive cervical cancer, speculum, vaginal and rectal examination, intravenous 
pyelogram (IVP) and abdominal ultrasound serves as the main guide for staging, but cystoscopy, 
proctoscopy, chest x-ray, skeletal x-ray or bone scan, abdominal or pelvic computed tomographic 
(CT) scan, magnetic resonance imaging (MRI), or positron emission tomography (PET) scanning 
can also be done to evaluate extent of the local lesion, metastasis to regional lymph nodes and 
distant metastasis (Itano & Taoka, 2005;  WHO, 2006). All these investigations are to determine 
the stage and the treatment to be employed (Itano & Taoka, 2005). Laboratory studies, usually 
done include complete blood count to look for evidence of anemia and chemistry studies to 
evaluate renal and liver function (Moore-Higgs, 2007) and blood for HIV and syphilis, may inform 
additional treatment (WHO, 2006). 
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2.7 HISTOLOGIC TYPES 
According to Itano and Taoka (2005), there are two main histologic types of cervical cancer, 
namely squamous carcinoma and adenocarcinoma. Squamous carcinoma is the most common and 
occurs in 85% to 90% of women.  According to Moore-Higgs (2007), approximately 7% to 10% of 
cervical cancers are classified as adenocarcinoma, which occurs in younger women and carries a 
poorer prognosis, has bulky endocervical tumours, which are aggressive in nature and is less 
responsive to treatment. 
2.8 STAGING 
Staging is according to the International Federation of Gynecology and Obstetrics (FIGO) and 
takes into account the clinical extent of disease, which includes the cervical biopsy findings, the 
class of cytologic interpretation and histologic grade (Varricchio, 2004). The stage ranges from 
Stage 0 to stage IVB, as presented in Table 2.1. 
Table 2.1. FIGO Staging of Cervical Cancer 
Stage  Description 
0 Carcinoma in situ 
I Cancer has invaded the cervix but has not spread anywhere else                                                                                     
Stage 1AI: Invasion is less than 3mm deep and less than 7mm wide                                                                                   
Stage 1A2: Invasion is between 3mm and 5mm deep and less   than 
7 mm wide                                                                 
1B1 The cancer is no larger than 4cm                   
1B2 The cancer is larger than 4cm 
II Cancer has spread beyond the cervix, but it is still within the pelvic 
area                                                                         
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IIA Cancer has spread beyond the cervix to the upper part (but not lower 
third) of the vagina                               
IIB Cancer has spread to the parametrial tissue next to the cervix 
III      Cancer has spread to the lower part of the vagina or pelvic wall. The 
cancer may be blocking the ureters                    
IIIA Cancer has spread to the lower third of the vagina but not pelvic wall                                                              
IIIB Cancer extends to the pelvic wall and/or blocks urine flow to the 
bladder               
IV Cancer has spread to nearby organs or other parts of the body             
IVA Cancer has spread to the bladder or rectum  
IVB Cancer has spread to distant organs beyond the pelvic area 
(Varricchio, 2004) 
2.9 TREATMENT FOR CERVICAL CANCER 
The choice of treatment is determined by the FIGO stage of disease (Varricchio, 2004). Primary 
treatment may be surgery or radiotherapy, or occasionally a combination of both; chemotherapy 
may be given concurrently with radiotherapy but is not a primary treatment (WHO, 2006). 
2.9.1 Treatment for Early Cervical Cancer 
 The International Atomic Energy Agency’s (IAEA, 2010) guidelines for treatment of early stage 
cervical cancer are as follows: 
 Stage IA1: Total abdominal hysterectomy with or without salpingo-oophrecteomy; if there 
are contraindications to surgery, the patient can be treated with intracavitary brachytherapy 
alone. 
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 Stage IA2: Radical trachelectomy and pelvic lymph node dissection (PLND) or modified 
radical hysterectomy and PLND with or without tailored adjuvant radiotherapy, if surgery 
is contraindicated, brachytherapy alone or in combination with external beam radiotherapy 
(EBRT). 
 Stage IB1-IIA1: If surgery, then modified radical hysterectomy and PLND with or without 
tailored adjuvant radiotherapy or definitive radiotherapy; if the patient is not fit for surgery, 
then definitive radiotherapy. 
2.9.2 Treatment for Advanced Stage Cervical Cancer 
Mainstay treatments for advanced stages are: 
 Stage IB2-IIA2: Modified radical hysterectomy in selected patients with postoperative 
radiotherapy, or radio-chemotherapy, based on histopathological features. 
 Stage IIB-IVA: These patients are not candidates for surgery and standard treatment is 
EBRT plus brachytherapy with or without concomitant chemotherapy. 
 Stage IVB: Radiotherapy with or without chemotherapy if microscopic para-aortic lymph 
node involvement, unless medical contraindications are present or if distant metastasis cure 
is not possible; treatment is palliative and radiotherapy may be useful in the palliation of 
specific symptoms. 
The indication from above is that approximately 60% of patients with cervical cancer receive 
radiotherapy at some point during the treatment of the disease (Newton, Hickey & Marrs, 2009). 
Chemotherapy is not a primary therapy, but may be given concurrently with surgery or radiation to 
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treat bulky tumors (WHO, 2006).  Ozsaran et al. (2003) also supports concurrent chemoradiation 
for locally advanced cervical cancer as treatment of choice in suitable patients providing high 
response rates with acceptable toxicity. 
2.9.3 Radiotherapy  
The goal of radiotherapy is to destroy or inactivate cancer cells, but normal cells are also affected 
and local tissue change caused by ionizing radiation can have systemic effects with alterations 
occurring in various physiological processes. The radiation effects on mammalian tissue should be 
viewed as a succession of processes extending from microseconds to months and years after 
exposure to ionizing radiation (Moore-Higgs, 2007). Side effects are a result of radiation on normal 
tissues and can cause acute side effects that occur during , weeks or months after radiotherapy, 
whilst late effects occur months to years after radiotherapy and are permanent (Itano & Taoka, 
2005). 
Acute effects of radiotherapy may be skin reactions ranging or progressing from mild 
hyperpigmentation, dry or even moist desquamation, acute cystitis which could result into dysuria 
where patients report increased frequency, urgency, hesitancy and increased nocturia, diarrhoea, 
vaginal mucositis where patients report symptoms of discomfort and dyspareunia, fatigue and bone 
marrow suppression (Moore-Higgs, 2007). 
Late effects of radiotherapy include proctitis which might lead to development of ulcers, strictures 
and rectal bleeding, haemorrhagic cystitis, early menopause, chronic lymphedema of lower 
extremities, fistulae may form between the bladder and vagina, vagina and rectum, bowel and 
vagina or bowel and bladder and also vagina stenosis which might cause sexuality problems 
(Moore-Higgs, 2007). 
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Burns et al. (2007) revealed a range of bladder problems after radiotherapy including urinary 
frequency and incontinence, which was a severe problem, but found even persistent mild 
symptoms had an impact on daily lives of women treated for cervical cancer, including sexuality. 
There was a link between cancer treatment and sexuality largely due to the physical problems and 
psychological difficulties in maintaining an effective sexual relationship. This is in line with a 
study conducted by Bloom, Petersen and Kang (2007) who reported micturitic problems as well as 
hot flashes and vaginal dryness. In this study, depressive symptoms, anger and confusion revealed 
a significant association between high levels of social support and less cancer specific distress. 
Furthermore, Bloom et al. (2007) seem to support the earlier findings of Juraskova et al. (2002) 
where common physical changes were reduced libido, shortened vagina and decreased lubrication 
implying high levels of sexual dysfunction. Vistad et al. (2011) also found that chronic pain was 
significantly more prevalent in women treated for cervical cancer than in women generally. 
2.10 SUMMARY 
This chapter provided the reader with literature related to the disease, incidence, risk factors, 
prevention, diagnosis, treatment and acute and late effects of radiotherapy. The following chapter 
presents the research methods. 
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CHAPTER 3 
RESEARCH DESIGN AND METHODS 
3.1 INTRODUCTION 
This chapter describes the research methods used in this study including the research design, the 
study setting, sample criteria, the sampling process, data collection and analyses procedures, the 
ethical principles underpinning the study and the measures applied to enhance the trustworthiness 
of the findings. 
3.2 RESEARCH DESIGN 
A qualitative research method and descriptive phenomenological design based on the tradition of 
Husserl (McCance & Mcilfatric, 2008) was used to explore the research problem. According to 
Burns and Grove (2007), qualitative research is a systemic, subjective methodological approach 
used to describe life experiences and give them meaning. Miller, (2010) also states that qualitative 
research refers to a method of inquiry in which the researcher, acting as data collection instrument, 
seeks to answer questions about how or why a particular phenomenon occurs. 
Descriptive phenomenological research insists on careful description of ordinary conscious 
experience of everyday life (Polit & Beck, 2012). Lopez and Willis (2004), describe Husserl’s 
philosophy to be experiences as perceived by human consciousness, which has value and should be 
an object of scientific study. Husserl believes subjective information is important to scientists 
seeking to understand human motivation, because human actions are influenced by what people 
perceive to be real and human beings generally go about the business of daily life without critical 
reflection on their experiences. Therefore, the study uses this scientific approach to bring out the 
essential components of the lived experiences of long-term effects in women who have received 
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radiotherapy for cervical cancer. This is the essence, referring to the most essential meaning for a 
particular context that forms the consciousness and perception (McCance & Mcilfatric, 2008).  
3.3 RESEARCH METHODS 
According to Polit and Beck (2012), research methods are techniques researchers use to structure a 
study and to gather and analyse information relevant to the research question. These research 
methods, discussed below, include the study setting, target population, sample and sampling 
method, data collection procedures and strategies for analysing the data. 
3.3.1 Study Setting 
The conducting of the study was at an academic hospital, in Gauteng Province, with 1088 beds 
serving patients from across the province and neighbouring provinces. The hospital offers 
specialist inpatient and outpatient services, serves as a referral hospital for a number of hospitals in 
its referral chain and holds professional and support staff of more than 4000 people.  
The hospital has various specialised departments. Cancer patients have access to surgery, 
chemotherapy and radiotherapy as major treatment modalities for management of cancer. The 
radiation oncology department delivers radiation treatment through teletherapy (EBRT) and 
brachytherapy, which is high dose rate (HDR), on an outpatient basis. Patients receiving 
radiotherapy are reviewed every week and those for follow-ups are seen on a specific day of the 
week. Women who have been treated for cervical cancer are also scheduled for follow up on a 
specific day each week (Johannesburg Hospital, 2013).  Approximately 360 women treated with 
radiotherapy for cervical cancer are reviewed every month.  
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3.3.2 Population and sampling 
The population, also referred to as the target population, is the entire set of individuals who meet 
the sampling criteria (Burns & Grove, 2007). The population for the study comprised all women 12 
months after completion of radiotherapy for cervical cancer. Purposive sampling was used to select 
participants who were 18 years and older, able to speak and understand basic English, diagnosed 
with cervical cancer and had completed radiotherapy 12 months prior to the gathering of the data. 
Purposive sampling is a judgemental or selective sampling method where certain participants are 
consciously selected for inclusion in a study (Burns and Grove, 2007). According to McCance and 
Mcilfatric (2008), purposive sampling is particularly suited for phenomenological studies as this 
sampling method allows the selection of participants with rich information from which the 
researcher can learn much in terms the of events, incidences and experiences of central importance 
for the study. Sixteen (n=16) women were recruited for the study and all were willing to 
participate. 
3.3.3 Data Collection  
Data were collected using open-ended, unstructured interviews. Unstructured interviews are 
interviews in which the researcher asks respondents questions without having a predetermined plan 
regarding the content or flow of information to be gathered (Polit & Beck, 2012). The researcher 
used the interview guide (Appendix D) which had only one open ended opening question and three 
probes. To maintain the focus of the study, all the participants were asked the same opening 
question: “Please tell me about the problems you are experiencing now, since you got the 
treatment for cervical cancer”. 
To ensure clear understanding of the question a pre-test was done using the first participant. A pre-
test is a trial run to determine, as far as is possible, whether the instrument is clearly worded and 
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free from major bias and whether it solicits the type of information envisioned (Polit & Hungler, 
1997). Since the question was well understood by the first participant it was not necessary to 
change it and the data were included as part of the study. 
After the initial question, each participant was expected to proceed with the expression of the 
problems she is experiencing. This was followed by probes such as “tell me more about” to elicit 
detailed exploration. According to Polit and Hungler (1997), probes are prompting questions that 
encourage the respondents to elaborate on the topic.  
Interviewing techniques commonly used were paraphrasing so as to enhance meaning, clarification 
for unclear statements and minimal verbal or nonverbal responses, summaries to confirm if 
researcher understood the participant clearly and occasional nodding “mmm, yeah, Ok, alright,” 
which encouraged the participants to talk freely and tell stories in their own words as they convey 
concern and interest (Polit & Beck, 2012). 
At the end of each interview, the researcher thanked the participants for being part of the study and 
asked for permission for a follow-up interview, should more information be required and to verify 
the findings.  
The researcher used bracketing throughout the study so as not to influence findings in anyway. 
Polit and Beck (2012) defines bracketing as the process of identifying and holding in abeyance, 
preconceived beliefs and opinions about the phenomenon under study. According to Lopez and 
Willis (2004), an essential component of Husserlian phenomenology is the belief that the 
researcher shed all personal knowledge to enable her to grasp the essential lived experiences of 
those being studied.  The guidelines of Ahern (1999) were used to bracket and the researcher 
reflected on anything she would take for granted whilst conducting the research, the power 
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hierarchy and potential role conflict. The researcher also clarified her personal value systems, 
acknowledged any subjectivity she might have had and attempted to recognise feelings that could 
indicate lack of neutrality.  
All interviews were audiotaped for verbatim transcription. Audiotapes contain more than words, 
they contain feeling emphasis and nonverbal communication, which are as important to 
communication as words (Burns & Grove, 2007). To enrich audiotaped interviews, field notes 
were written during and immediately after the interviews and inserted and validated at relevant 
points during transcription. Field notes represent the participant observer’s efforts to record 
information and synthesise and understand the data (Polit & Beck, 2012). Each interview lasted 
approximately 60 minutes, followed up by shorter interviews of approximately 20 to 30 minutes, 
when the researcher needed additional information and clarify issues. 
Data analysis commenced immediately after the first interview and continued with on-going data 
collection. Sixteen participants were interviewed in order to obtain greater richness of data for the 
study.     
Planning for the data collection was as follows: 
 Permission to conduct the study was obtained from the Post Graduate Committee of the 
University of the Witwatersrand (Appendix F), Human Ethics Committee, (Appendix G) 
and the CEO of the hospital (Appendix E). The head of the Department of Radiation 
Oncology and the Unit manager also supported the study. 
  The researcher had been practicing, as a registered nurse, in the radiation oncology 
department prior to collection of data and was familiar with the setting. The researcher 
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purposively selected participants to be included in the study. Once the participant was 
identified, the researcher personally approached and invited her to participate after 
explaining the study (Appendix A), informed consent (Appendix B) for inclusion in the 
study was obtained and permission for voice recording was sought, if they agreed consent 
for recording (Appendix C) was obtained. 
 The interviews were conducted in a private room and the seating was arranged in such a 
manner that it allowed the participant and the researcher to communicate freely. 
 The in depth interview process started in an informal and friendly manner. According to 
Polit and Beck (2012), interviewers must prepare respondents for the interview by putting 
them at ease as part of this process involves sharing pertinent information about the study. 
The introductory phase involved explaining to the participants the purpose of the study, 
their expected role, the amount of time needed to complete the interview and the use of the 
voice recorder. The first few minutes also helped both parties to settle in (Polit & Beck, 
2012).  
 At the beginning of the interview, the participants were informed of the measures that 
would be taken to protect anonymity and confidentiality. Demographic data were collected 
before the interview. 
3.4.4 Data Analysis 
Data analysis is the systemic organisation and synthesis of research data (Polit & Beck, 2012). 
Data collection and analysis occurred concurrently as interviews were transcribed verbatim 
immediately after the interview. The Colaizzi method (Polit & Beck, 2012) was used to analyse the 
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data. The Colaizzi seven-step procedure for analysis is, according McCance and Mcilfatrick 
(2008), an appropriate data analysis framework for Husserlian phenomenological research.  
The steps of the data analyses process (Polit & Beck, 2012) were applied as follows: 
Step 1: Read all protocols to acquire a feel for them.  
 All the transcribed interviews were read and reread until the researcher had a full 
understanding of the content. 
Step 2: Review each protocol and extract significant statements.  
 After the researcher had a full understanding of the content and she highlighted significant 
statements in each transcribed interview using different colours; statements with similar 
problems experienced had one colour, continuing with different colours of highlighters for 
different problems experienced. 
Step 3: Spell out the meaning of each significant statement.  
 At this stage, the researcher looked for the meaning of each colour code of the significant 
statements highlighted as in step 2. 
Step 4: Organise the formulated meanings into clusters of themes.  
 At this point, the researcher had four broad themes identified: physical problems, socio-
economic issues, psycho-spiritual issues and sexuality. Each major theme had 
subcategories, which were clusters of similar problems experienced. There was also a fifth 
broad theme with a few problems experienced which did not fit into the four major themes 
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identified but were considered important to the study, therefore, it was called health system 
setbacks. 
Step 5: Integrate results into an exhaustive description of the phenomenon under study.  
 After identification of the major themes, the researcher gave a detailed description of how 
the women, living with cervical cancer, experienced the effects of radiotherapy 12 months 
after completion of the treatment.  
Step 6: Formulate an exhaustive description of the phenomenon under study in a statement of 
identification as unequivocal as possible.  
 While describing the late effects women experienced 12 months from completion of 
radiotherapy treatment in relation to the identified themes, the researcher was able to add 
some narrative statements, which give identification, from participants having experienced 
the phenomenon under study 
Step 7: Ask participants about the findings thus far as a final validating step.  
 The findings were presented to the participants and the researcher confirmed it to be a true 
reflection of their experiences relating to themes that had emerged from the transcribed 
interviews, which is also the phenomenon under study. The researcher informed the 
participants telephonically and was able to do so, as she had gotten permission at the end of 
the interviews to contact them if there was need for more information and to validate the 
findings. 
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3.4 MEASURES TO ENHANCE TRUSTWORTHINESS 
According to Polit and Beck (2012), trustworthiness answers the question on how one can trust that 
the researcher has offered an accurate and insightful representation of the phenomenon 
investigated. Rolfe (2004) however, is of the opinion that a study is trustworthy only if the reader 
of the research report judges it so. Lincoln and Guba’s framework, as explained by Shenton (2004), 
was applied in the current study to ensure the findings are a true reflection of the women’s 
experience.  
3.4.1 Credibility 
 Credibility refers to the confidence in the truth of the data and interpretations of them (Polit & 
Beck, 2012). The following measures applied, according to Shenton (2004), were to enhance the 
credibility of the findings  
 Early familiarity with culture of the participating organisation: Before data collection 
commenced, the researcher was already placed at the site of data collection. 
 Measures taken to ensure honesty in the informants: Participants were given the 
opportunity and informed they were free to refuse to participate in the study so that only 
those genuinely willing participated and offered data freely with honesty. 
 Iterative questioning: The researcher used probes during the interviews to elicit detailed 
data and rephrasing questions to return to matters previously raised by participants to 
ensure what was recorded was exactly what the participants said. 
 Member checks: Checks relating to the accuracy of the data took place on the spot by 
paraphrasing the questions and the researcher would give a summary at the end of the 
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interview to check if she had recorded according to what was being said by the participants. 
The researcher also audio recorded the interviews and when transcribing both verbal and 
non-verbal expressions were transcribed. At the end of data analysis, verification of the 
emerged themes was done where participants confirmed the emerged themes were a true 
reflection of the data collected during the interviews. 
3.4.2 Dependability 
Dependability refers to the stability, that is, reliability of data over time and conditions (Polit & 
Beck 2012) and according to Shenton (2004): 
 The research design and implementation has to be explained in detail. A detailed 
explanation of the research design and implementation has been given and this allows for 
dependable results and the study to be repeated. 
3.4.3 Transferability 
Transferability refers to the extent to which findings can be transferred to or have applicability in 
other settings (Polit & Beck, 2012). Shenton’s explanation (2004) was employed as: 
 Sufficient description of the context, the number of participants, data collection methods 
employed and limitations has been provided 
  to allow extent of transferability of the results and comparisons can be done.  
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3.4.4 Confirmability 
Confirmability is concerned with establishing that data represents information participants 
provided, findings reflect the participants voice and not that of the inquirer/researcher (Polit & 
Beck, 2012). 
 An in-depth methodological description of the study has been given and Shenton (2004) is 
of the view that this allows for scrutiny of the research results. 
3.5 ETHICAL CONSIDERATIONS 
The ethical guidelines from the Belmont Report (Polit & Beck, 2012) were applied in the study. 
The Belmont Report describes three broad principles on which to base standards of conducting 
research in an ethical manner: beneficence (minimise harm and maximise benefits), respect for 
human dignity (right to self-determination and full disclosure) and justice (right to fair treatment 
and privacy).   
To ensure the above principles were adhered to, the following were applied: 
 The proposal of the study was presented to the Department of Nursing Education and the 
University Post Graduate Committee for peer review and permission to commence the 
study was granted. 
 The proposal was presented to the Human Ethics Committee of the University of the 
Witwatersrand and ethical clearance was granted.  
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 Permission to conduct the study was obtained from the Chief Executive Officer of the 
hospital (appendix E). The head of the department and the unit manager of the Oncology 
Unit also supported the study. 
 An information leaflet was first given to the participants (Appendix A), whereafter 
informed consent was obtained (Appendix B) from those willing to participate in the study 
and consent to audio tape the interviews (Appendix C) was also obtained. Interviews were 
conducted in a private room. 
 Human dignity was respected, including the right to self-determination, as participants were 
made aware of their right to withdraw freely from the study if they so wished, with no 
effect on their care. Confidentiality measures were adhered to, by not divulging the 
information obtained and using it only for the intended purpose. 
 After the transcription, the interviews were transferred to a CD and deleted from the 
computer. All data sheets and the CD were sealed in an envelope and placed in a safe in the 
Department of Nursing Education, to be kept for a period of three years after the report has 
been published whereafter it will be destroyed. 
3.6 SUMMARY 
In this chapter, the research design and method of the study were described in detail. Measures to 
enhance trustworthiness as well as ethical considerations were discussed. 
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CHAPTER 4 
FINDINGS AND DISCUSSION 
4.1 INTRODUCTION 
In the previous chapter, the research design and method were provided. This chapter presents the 
findings and discusses the major themes that arose with regard to the views and opinions of the 
participants about women’s experiences of long-term effects of cervical cancer and its treatment. 
To begin with, the biographic information of the participants has been presented, followed by the 
discussion of the findings, a brief conclusion of the findings and a summary. 
4.2 PARTICIPANTS 
The average age of the participants was 44 years and ranged from 27 to 59 years. Most were single 
and lived in urban communities. Nearly one third of the participants did not have a personal 
monthly income, whilst the rest had a monthly income ranging from R870 to R6650. The 
participants were diagnosed with cervical cancer ranging from stage IB to stage IV and all had 
received external beam radiation, either alone or in combination with brachytherapy and 
chemotherapy. A detailed description of the demographic data of participants is presented in Table 
4.1.  
Table 4.1 Demographic information of the participants (n=16)  
Characteristic  n 
Age group  
     20-29  1 
     30-39 3 
     40-49 7 
     50-59 5 
Marital status  
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     Single 8 
     Married  5 
     Widowed 3 
Residing place  
     Urban 12 
     Rural 4 
Monthly personal income   
     No income  5 
     R1 to R2000  7 
    R2001 to R4000 3 
    R4001 to R6000 0 
    R6001 to R8000 1 
Stage of disease  
    IB to II 4 
    IIA to III 9 
    IIIA to IV 3 
Treatment   
    External beam radiation only 1 
    External beam radiation and brachytherapy 11 
    External beam radiation, brachytherapy and chemotherapy 3 
    Surgery, external beam radiation and  brachytherapy 1 
 
To introduce the participants to the reader, a succinct history of each participant is provided in 
Table 4.2 
Pseudonym Age Marital 
status 
Personal 
Monthly 
income(R) 
Place of 
residence 
Stage of 
disease 
Treatment 
received 
Mary 30 Single Nil Urban IIB External beam 
radiation  and 
brachytherapy 
Rose 46 Married 1000 Urban IIB External beam 
radiation  and 
brachytherapy 
Mwaba 59 Single Nil Urban IB External beam 
radiation  and 
brachytherapy 
Jane 35 Single 870 Urban IIB External beam 
radiation, 
chemotherapy and 
brachytherapy 
Eunice 43 Single Nil Rural IV External beam 
radiation  and 
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brachytherapy 
Annie 54 Single 6650 Urban IB Surgery, external 
beam radiation  and 
brachytherapy 
Hildah 54 Widow 1100 Urban IB External beam 
radiation  and 
brachytherapy 
Suzie 37 Widow 3500 Urban IIA External beam 
radiation  and 
brachytherapy 
Maggie 41 Single 1500 Rural IIIB External beam 
radiation  and 
brachytherapy 
Karen 41 Married 4000 Urban IIB External beam 
radiation  and 
brachytherapy 
Maureen 40 Married Nil Urban IIB External beam 
radiation, 
chemotherapy and 
brachytherapy 
Diana 44 Married Nil Rural IIIB External beam 
radiation  and 
brachytherapy 
Nana 47 Widow 1200 Urban IIIB External beam 
radiation  and 
brachytherapy 
Ezra 50 Married 3500 Urban IIB External beam 
radiation  and 
brachytherapy 
Carol 27 Married 1000 Urban IIB External beam 
radiation  and 
brachytherapy 
Fenny 57 Single 1200 Rural IIB External beam 
radiation  and 
brachytherapy 
 
Five themes arouse from the data:  
 Physical consequences; 
 Socioeconomic problems; 
 Sexual problems; 
 Spiritual issues; 
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 Health system challenges.  
4.3 THEMES ARISING FROM THE DATA 
4.3.1. Theme 1: Physical consequences 
Participants experienced various physical problems related to the treatment they received namely 
chronic fatigue, bowel, bladder, vaginal and hormonal problems, pain and insomnia. 
Chronic fatigue was a major problem for most and participants described their fatigue as “getting 
tired,” “dizziness” and “weakness.”  The chronic fatigue women experienced had a negative 
influence on their daily lives as it limited their normal activities of daily living such as cleaning 
their homes and preparing meals. Mary described her experience: 
“During the day am alone at times and I have to cook and fix things I feel dizzy, during the 
day yes, the heart pumps very fast as if something wrong is going to happen like, cleaning, 
cooking, fetching water, I feel something bad, I cannot go out of the house.” 
Hildah said: 
“…am just tired sometimes, I just make food, clean the dishes and then am tired and just lie 
on the bed, generally sometimes I woke up in the morning when I go to preschool to take 
my granddaughter, when I come back I feel tired you know, just make some tea and some 
breakfast when I finish I lie in bed.” 
Most participants experienced chronic pain described as general body pain, pain in the abdomen, 
back and joints. The chronic pain some experienced added to their suffering as it influenced the 
activities of daily living negatively. Jane explained how her pain experience influences her life: 
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 “I feel pain [pointing at the lower back and abdomen]……always there……especially at 
the back, I take pain killers and go to sleep but when I woke up the pain is there, last night 
the pain got worse…I can stand for only two hours but not three hours then the pain is 
worse…”  
Hilda said: 
“…just that pain which comes and goes, comes and goes…..you know this back pain when 
it comes, I feel like screaming, I feel like, am just thinking, oh my God, why, why this pain 
come now, I must do this and this and this, but I can’t because of the pain,…sometimes I 
drink water, it helps sometimes…”   
Some participants developed lymphedema in their legs, which they experienced as painful and 
added to their suffering. Fenny explained: 
“…….you feel it every month and am changing in my legs, look at me [showing her legs], 
you see, look at my legs, you see it pains every day…I can’t walk.”  
The location of the pain determined whether participants had the confidence to report it. Women 
who experienced back and abdominal pain reported their pain during follow-up consultations, but 
those who experienced shoulder pain were reluctant to mention it as the medical personnel would 
tell them it was not directly related to their cancer and therefore their pain was not managed. Ezra 
explained: 
“…it’s just pain here, and when I come to tell the doctors I have pain here and here 
[pointing arms and joints] the doctors said no, am working here for the cancer not for the 
pain here and here, I also have got the problem but I can’t tell them…”  
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Participants also experienced vaginal problems and reported suffering from pain, vaginal stenosis, 
dryness, itchiness, rash and discomfort, vaginal bleeding and discharge.  Fenny who experienced 
vaginal pain and dryness described her experience as follows: 
“…I was feeling pain in my vagina, aaaaa sometimes my vaginal became too dry, and that 
vaginal cream it helps a lot, we must have it a lot because from that you feel hot you know, 
you can feel it deep in your vagina…..you feel something and you feel fresh.”  
Annie described her vaginal bleeding and Maureen her slight vaginal bleeding and stenosis as 
follows: 
“….I was bleeding through the vagina, but it’s not too much, you see when you go to the 
toilet then you see blood” (Annie). 
“…. The vaginal is small that’s the main one, that one……bleeding small not serious” 
(Maureen). 
In addition to the problems already described, women also experienced bowel and bladder 
problems. Bowel problems consisted of diarrhoea, constipation and proctitis, whilst bladder 
problems consisted of dysuria, urgency and urinary incontinence. Some participants also had 
vesico-vaginal, even recto-vaginal, fistulae.  
Diana explained how her recto-vaginal fistula influenced her life: 
 “After a year, eeee I found out that the poo (stool) comes out through the vagina…it wasn’t 
painful but disgusting, cause you can’t just walk freely because anytime it comes out a lot 
so that poo I had to go for this colostomy…then after that I was okey but now I have got 
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problem of urine….it’s like I can’t hold urine… I have to go to the toilet now…that’s my 
problem…” 
Carol described her experience as follows: 
“…bleeding sometimes it’s heavy, it’s thick, sometimes it’s not coming through the womb 
the cervix, it’s coming where I get urine…  it’s painful….blood comes through the urine, so 
it’s blood then urine sometimes the blood block the urine to come out.”  
A couple of participants experienced hormonal problems like hot flashes and early menopause. 
Rose explained how her body changed after treatment: 
“………eeeee but my body was changing, eeee I didn’t have eeee menstruation was 
stopping, the other thing eeee, I think I had, two years after that eeee something like am not 
the same…”  
Maureen experienced hot flushes and said: 
“I don’t have many problems…..eeeee hot flushes…..it’s just sometimes you feel like you 
don’t have feelings anymore  but not always……yeeee hot flushes heeee…when you put 
makeup, when you go out you feel like you are sweating, like you never put makeup, that’s 
how it’s affecting me.”  
Participants experienced insomnia as a result of pain and unknown causes. Maggie said:  
“Am not sleeping well, because am in pain…”  
Maureen did not know why she was experiencing insomnia: 
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“Am sleeping but since I had treatment I woke up maybe at 2 am in the morning until 4 o’ 
clock in the morning…..I don’t know, I don’t know, everyday.”                                    
4.3.2 Theme 2: Socioeconomic consequences  
The physical problems participants experienced influenced women’s lives negatively and resulted 
in financial hardship, social problems and body image changes. Most of the women experienced 
financial difficulties, being unable to work because of the chronic fatigue. Those who were able to 
work could not do hard physical work or lift heavy things, or could not work every day thereby 
reducing their monthly income.  
Maggie said: 
“I feel weak, I feel my heart, when I clean my house, eish it’s too much, ….I am not 
working right now so life is tough, my children are suffering from January till now, they go 
to school no transport, food they are suffering, my husband the money it’s not enough…to 
buy groceries, food and everything, it’s not enough.”    
Suzie who had to provide not only for her own children but also for her mother and sisters 
explained: 
 “ …because maybe if am working, that’s why I feel tired, am working what I want to work, 
I just work because I have to pay rent, buying is a problem to me, my husband does not 
work so am alone. I am working five days my boss said you must work four days to support 
my kids, my mother and sisters.”  
Rose explained how she had to decrease her working hours: 
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“...it’s affecting my work because that time, I left the work and then asked them to give me, 
maybe twice a week, so they gave me twice and sometimes three times a week…I cannot 
work every day because am getting the pain in the hand...even the money cannot get so 
much…pay according to work.”  
Jane said: 
“…….everywhere gets swollen like something was beating me, I can’t even able to work 
and that’s the problem……I have to work for my children… I want to work for my children 
but I can’t, it’s difficult [sobbing]…”  
Some women experienced anxiety worrying something “wrong” would happen, the changing 
attitudes of their husbands, sleeplessness, their children suffering, pain and stress. In addition, the 
fact that some participants were solely responsible for their children added to their suffering. 
Maggie explained her experience: 
“Heish it’s too much….my husband nay, he is not feeling alright with me, he has changed, 
complaining everything that I feel alright, I do not feel alright, he is saying am sick.”  
Carol said: 
“….so you have to take care of yourself, your children, you buy everything for them, school 
fees, clothes to put on, everything, so that’s why am very worried…”  
The women also found it challenging to return to the hospital for follow-up visits, as they did not 
have money for transport. Fenny described her experience: 
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“…they said I must come back for the blood but I didn’t have money to come you know if 
you are not working…”  
Some participants were abandoned by their partners because of the disease and therefore lost the 
financial support provided by them, leaving them to care for themselves and their children. Fenny 
explained: 
“When your husband want to have sex, the bleeding is coming out, it draws my husband 
away from me, it draws my husband away till today…..we are the women…to look after the 
children while these men are going away leave us with these children…”  
Some women experienced anxiety worrying something “wrong” would happen, the changing 
attitudes of their husbands, sleeplessness, their children suffering, pain and stress. In addition, the 
fact that some participants were solely responsible for their children added to their suffering. 
Maggie explained her experience: 
“Heish it’s too much….my husband nay, he is not feeling alright with me, he has changed, 
complaining everything that I feel alright, I do not feel alright, he is saying am sick.”  
Carol said: 
“….so you have to take care of yourself, your children, you buy everything for them, school 
fees, clothes to put on, everything, so that’s why am very worried…”  
Some women experienced body image changes, which were expressed as the “body not the same” 
and “no feelings like a woman.” Not having pubic hair was also a problem for some of the 
participants, which robbed them of being women and turned them into babies. Diana said: 
39 
 
“And as you see the hair is not there as a woman, just the hair is not there after radiation, 
like a baby.”  
Being incontinent was another problem women faced, as it changed their way of dressing and 
reduced their freedom and influenced their social lives, as they always had to check that they had 
not soiled themselves. Diana and Nana said:  
 “I am worried….. I can’t be free all the time, I have to check all the time maybe it’s wet on 
the trousers or on your skirt….now is my main worry…” (Diana) 
“…..you see now I have to cover with a blanket here [pointing at the small blanket she has 
wrapped around her hips] and you see I wear two skirts….it’s a problem for people not to 
see and then you can’t go to people’s houses, he is going to say that what’s wrong now… 
you are worried what if I wet the bed, it’s very bad to the people, even at home you must go 
fast because it will come out and then what if you are in somebody’s house, it’s a big 
problem.” (Nana)   
Participants were fully aware of the necessity to prevent vaginal stenosis by dilating their vaginas 
daily. However, their socio-economic status did not always award them the opportunity to perform 
this procedure as some shared one-roomed dwellings. The facilities provided at work were also not 
conducive for vaginal dilations due to having access only to communal toilets and showers and the 
only free time was the hour lunch time. Karen said: 
 “The problem is that sometimes I do not have privacy, because you have to be at work and 
my child is old now, so I do not have privacy…when they are at school am at work, at work 
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time is only at break, but what can I use the toilet…there is only one toilet we share. 
Lunchtime… I’ve got only one hour…”  
Support from family members had a positive influence on the lives of some of the participants and 
helped to cope. The support mainly came from parents, children, spouses and other family 
members. The support was in terms of finance, performing household chores and encouragement. 
Mary explained: 
“I get a lot of support with my parents…”  
Rose added: 
“…..I like it because my family from that time…they support me too much, my children and 
husband support me …even the food my daughter, she would say mummy I buy you fruits, I 
buy you and you must eat, they support me too much and my son, they support me they even 
buy for me the tablets for appetite, I can’t feel like am so lonely and then sometimes, I 
thought that I had no cancer before hahahaha…” 
4.3.3 Theme 3:  Sexual problems 
The physical consequences of the disease and treatment had a negative influence on the sexual 
relationships of participants. Some experienced that their spouses were unable to cope with their 
altered sexuality caused by their vaginal changes. Some of the women experienced their husbands 
complaining that their vaginas were short, dry and tight, they did not want to have sex because the 
participants were tired, had waited long before resuming sexual intercourse and thought sex was 
painful for women. Rose explained: 
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“Usually my husband eeee, because I was, my vagina was changing, my vagina was 
becoming short and so they gave me the KY jelly to be used… it was hard because my 
husband was complaining that my vagina is not the same like he knows, it was hard, it was 
paining when we meet. He said to me I must go back to the doctor to tell that there was a 
problem.” 
Maggie described her experience: 
“Heish it’s too much, my husband nay, he is not feeling alright with me, he has 
changed…he is saying am sick…it’s not okey, he doesn’t want to have sex because I feel 
tired, he just complains.” 
Karen added: 
“Yea eish this thing is affecting my life, the vagina sometimes my boyfriend came, if you 
want to make sometimes my vagina is tight, tight, tight, tight, he is complaining, he is 
complaining, its worrying me a lot, he has to push and push and push…” 
Some participant expressed how they engaged in sexual intercourse merely to satisfy their spouse, 
without them or their spouses enjoying this intimacy. Maureen said: 
“He is not having sex because he thinks it’s painful…..I think he doesn’t enjoy sex anymore 
because I can see eeee hahahaha I can see, I can see that aaaaa not like before 
anymore…..I can see it because we don’t sex like before, he takes long, I can see it he is 
just doing to satisfy me, I was worried but am fine, I understand what he is going through.” 
Diana explained: 
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“ The feeling to have sex like a woman is not there, but I can’t tell him that, I can’t tell him 
that, sometimes maybe let’s say when he feels like, if he wants to, it’s better if I feel that 
time, but if he wants me in that moment even if I don’t feel like…..If you are a woman, you 
have to sleep with your husband anytime that he wants, but he touches and there is 
nothing… it can be so bad….yea if he wants something he wants now you must give him 
what he wants, if not it might be a problem” (Diana). 
Some participants experienced a loss of desire for sex, as they no longer had “feelings like a 
women”. Carol described her experience: 
“I don’t want sex anymore, am not feeling like to have sex, my feelings it’s not there, just 
because am feeling that am sick I do not want my husband anymore…..also my husband 
takes long or even if I had some feeling that I want sex but my husband I think he is also 
have problems about sexuality, it takes long to meet me to have sex so that’s why sometimes 
I lose appetite and that’s why am feeling pain inside when I have sex, even if I tell him, he 
said that he is not feeling to have sex……so even if I have feelings where can I get a man to 
have sex with, I just sleep and have dreams and forget about that.” 
4.3.4 Theme 4:  Spiritual issues  
Spiritual issues also resulted from the physical problems the participants experienced. Most 
participants blamed themselves for their life situation, for not having enough money to buy food 
and visit loved ones and seeing children fighting. They also experienced cancer as a neglected 
disease and were afraid of death.  “Why me?” was a question they asked God very often. Hildah 
said: 
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“….just like that, last year my sister passed away, then last year again my granddaughter 
passed away yoooo, it’s just like that and am asking why why…”  
Ezra said: 
“Sometimes eeeee my children they spoke, am bad, am bad, am bad…..my children they 
fight….I don’t know, I don’t know, this is affecting me too much, too much, too much…”  
Fenny experienced cancer to be a neglected disease with those suffering from AIDS getting 
preference. She said: 
“…now people are crazy with AIDS, all the money about HIV/AIDS they are running round 
for people with HIV/AIDS, what about us?... what about cancer?” 
Carol’s experience of the consequences of her disease and treatment created anxiety about dying 
and the care of her children. She said: 
“Aaaaa because am not feeling well in the body, the urine is not coming to the way, the 
blood is coming to the other side why? And am thinking about my children they are still 
young, no one who can look after them since I have no mother, no father, am the only one 
to look after them, if am dying no one can take care of my children so am very very worried 
about my life…”  
Most participants experienced prayer and faith in God as a source of hope and strength. They 
believed that with God everything would be “alright”. A belief in God as all knowing also helped 
them to have courage and confidence as Annie, Maureen and Carol explained: 
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 “I believe in God, to move on yes……but if the doctor says do this, you must do it,….but I 
told God, if you believe in God, nothing can happen to you, and if you have got cancer, it’s 
not the end of the world, your time will come when everybody is going to die….you see 
when you look at me who can tell I have got cancer, nobody, nobody, but am telling you 
since 2006” (Annie). 
 “Just the prayer hehehehe, I just feel good you know, hmmmm, you just say dear God help 
the doctors to see if there is something wrong from there you take it from there” (Maureen). 
 “Only to go to church to pray, yes to invite God in my life to help me, to save me to all 
these situations, I believe in God, yea to give me hope and power to come to the doctors if 
the doctor say that your problem is this and that then I go to God to tell God, to tell God 
that I have got this and that, the only way to survive it’s you most to give me strength, to 
give me power to overcome this situation, you are the only one who can save me, who can 
heal me” (Carol). 
4.3.5 Theme 5:  Health system challenges 
The health care system added to participants’ suffering. Participants were of the opinion that they 
received no assistance with health problems at primary health clinics, for as soon as their status as 
a cancer patient was known, they were referred to the hospital where they were treated. 
Conversely, they were of the opinion that the medical practitioners at the cancer clinics only focus 
on cancer and do not take notice of other health problems, leaving them without the health care 
they needed. In addition, having to travel to hospitals for treatment posed the challenge of distance 
and cost. Fenny described her experience: 
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 “… the chemo, the radiation helps a lot but we need as cancer patients we need to have a 
little clinic, a special doctor near to our clinics so that if we are sick, they can help us…I 
start at 4 o’clock to here, I didn’t  have money and am sick, when we go to the clinic they 
said we are not treating cancer here, you see, will you please go to….”  
Ezra said: 
“….doctors said no, am working here for cancer not for pain here and here…..I also have 
got the problem but I can’t tell them…”  
Participants also experienced an information deficit and felt they received inadequate information 
and health education about cancer, cancer treatment, the side effects of treatment and the 
importance of follow-up consultations. Hildah expressed her experience as follows: 
“Ahhhh I don’t know, heee why we must keep here, why we must come to check every 
month, every year, every month, every year, check the doctor check” (Hildah) 
Diana said: 
“You know what, the people say that there are medicines that you must take like the 
mixtures, the herbal mixtures, and the many other things that you can take so I wanted to 
ask, how possible to use these things”  
Carol concluded: 
“Aaaaa I can ask that this cancer as you are studying you know much than me you know 
better than me, I didn’t know anything…”  
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4.4 DISCUSSION  
The study provided evidence that women treated with radiotherapy for cervical cancer experience 
various late effects due to the treatment and the disease. These experiences result in various 
physical problems, which have a negative influence on their social, economic and sexual lives.  
Chronic fatigue expressed as “weakness” and “getting tired” was a major problem for these women 
and is nothing new, as this is a well-known phenomenon in patients treated for cancer. Maree, 
Mosalo & Wright (2008), in a South African study exploring the most common symptoms in 
patients suffering from advanced cancer, found a high prevalence of fatigue and Vistad et al. 
(2007), in a study conducted in Norway, found chronic fatigue a problem for cervical cancer 
survivors. Suffering from chronic fatigue had a negative influence on women’s lives – domestic 
chores were burdensome and they were unable to work to earn an income, a situation adding to 
their burden, as they were concerned about how they would take care of their families. The health 
care system also added to their financial suffering by not providing primary health care services at 
their local clinics, but referred them back to the hospital, a costly exercise for women already 
struggling to attend scheduled follow-up visits due to the lack of transport money. It is known that 
cervical cancer is a disease of poor and disempowered women (Denny, Quinn & 
Sankaranarayanan, 2006) with the public health care system failing women in terms of early 
diagnosis (Van Schalkwyk, Maree & Wright, 2008; Maree, Langley & Nqubezelo, 2014), but 
evidence could be found in support of the finding of the health care system’s failure to provide 
primary health care services to patients with cancer. This is disturbing as it adds to the burden of 
cancer patients.  
It was interesting to find that pain, especially back pain, remained a problem and whether this is 
disease and treatment related is unclear. Andreyev (2007) found nearly one third of all patients 
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would experience some degree of abdominal or rectal pain after pelvic radiotherapy and that the 
nature of the pain experienced was such that it influenced daily living; a finding supported by the 
current study. 
Bowel and bladder effects related to cervical cancer and its treatment were a great challenge to the 
women and added to their suffering. Burns et al. (2007), in a study focusing on assessing the 
impact of late treatment effects in cervical cancer conducted in the UK, revealed a range of bladder 
problems after radiotherapy to the pelvis, including urinary frequency and incontinence. The bowel 
problems support the findings of Abayomi, Kirwan and Hackett (2005), who found most women 
described how bowel problems often re-appeared after the period of recovery; diarrhoea could 
either be continuous or alternate with periods of constipation.  
Experiencing bladder and bowel symptoms not only changed the way women dressed, as 
evidenced by “you see I wear two skirts,” but also influenced their social lives expressed as “it’s 
you can’t go to people’s houses.”  Burns et al. (2007) found even persistent mild bladder symptoms 
had an influence on the daily lives of women treated for cervical cancer. Lukazc et al. (2012), in a 
study investigating how accidental bowel leakage influences the quality of life of women living in 
the US, support the findings of the current study by describing how the changes in participation in 
social activities led to feelings of frustration and influenced the emotional health of the participants 
in their study. When exploring how women living in the community manage their fecal 
incontinence, Peden-McAlpine, Bliss and Hill (2008), found they had to consider the distance from 
home before accepting invitations to participate in social activities. The anxiety about the risk of 
accidents in public places brought a sense of discomfort of being in a public place and limited 
women’s ability to engage in productive work outside the home. Hagglund and Ahlstrom (2007), 
in a Swedish study focusing on the meaning of women’s experience of living with long-term 
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urinary incontinence, found some women had to plan their working days with reference to access 
to a toilet. 
The study provided evidence that the women experienced various vaginal problems which had an 
influence on their sexual lives. Lack of privacy expressed as “I do not have privacy” prevented 
some from dilating their vaginas, adding to sexual dysfunction caused by the shortening and 
dryness of their vaginas. Vistad et al. (2006), in a study conducted in Norway, also reported 
vaginal dryness, whilst Saewong and Choobun (2005) explain that radiotherapy directly affects 
vascular and genital elasticity tissue resulting in shortening and narrowing of the vagina causing 
patients to experience dyspareunia or difficulty in penetration.  
Women in the current study also experienced dyspareunia described as “it was paining when we 
meet” and difficulty in penetration described as “he has to push and push and push…” The sexual 
dysfunction caused worry amongst the women, “it’s worrying me a lot,” leading to sex being done 
only to satisfy or please the spouse and a loss of sexual desire. Burns et.al (2007) support these 
findings, as the participants in their study also experienced anxiety about sexual activity and lacked 
interest in sex which had an adverse influence on intimate partner relationships. Mercadante et al. 
(2010) are however of the opinion that sexual dysfunction is often both physical and psychological. 
It is therefore quite possible that the spouses, who complained how the vagina was short, dry or 
tight, took a long time to resume sex thinking it was painful for the women, which could have 
added to the women’s sexual dysfunction.  
As supported by “…am not feeling well in the body…very, very worried about my life…” spiritual 
problems were mainly due to physical, social and economic problems the women were 
experiencing. Women were anxious because their husbands complained they were sick and were 
worried due to the financial difficulties they were experiencing and being unable to adequately take 
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care of their families especially children, eventually they were unable to sleep, blamed themselves 
and viewed cancer as a painful disease. It is therefore quite reasonable to say some of the women 
experienced spiritual distress. 
 According to the North American Nursing Diagnosis Association (2001), spiritual distress is 
defined as “the disruption in the life principle that pervades a person’s entire being and that 
integrates and transcends one’s biological and psychosocial nature.” Villagomeza (2005), in a 
study on spiritual distress in adult cancer patients, described spirituality in relation to 
connectedness, faith and religious belief system, value system, sense of meaning and purpose in 
everyday life and amidst suffering, sense of self-transcendence, sense of inner peace and harmony 
amidst chaos of life and sense of inner strength and energy which is integrative and unifying 
beyond the physical realm. During spiritual distress, the patient loses hope, questions his or her 
belief system, or feels separated from his or her personal source of comfort and strength 
(Villagomeza, 2005). In the current study, the majority of the women explained how belief in God, 
through prayer and going to church, was a source of strength and hope to help them cope and they 
had confidence in God as all knowing and that everything would be fine.   
As supported by “I didn’t know anything,” the study has provided evidence of a lack of 
reinforcement of information and education on cancer, its treatment, side effects of treatment and 
the importance of follow-ups. Burns et.al (2007) support this finding and revealed that the women 
in their UK study also felt there was inadequate provision of information about treatment effects. 
This is contrary to the WHO’s (2006) recommendations on the management of patients with 
invasive cancer, which stipulates these patients have to be made aware they will need long-term 
follow-up, have contact with the cancer unit where they received treatment and need information 
about late complications after radiotherapy. 
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It was positive to find that a good support system played a huge role in women’s lives, as those 
supported by their families and relatives were able to cope and move on with life despite the 
physical or social problems being experienced; “they support me too much…” and “I thought that I 
had no cancer before…” serves as evidence. Bloom et.al (2007), in a study conducted in Europe 
focusing on multi-dimensional quality of life amongst long-term adult cancer survivors, showed 
that depressive symptoms, anger and confusion revealed a significant association between high 
levels of social support and less cancer specific distress. Maree et al. (2013), in South African 
study, found women whose life partners were caring and supportive, seemed to be in a better 
position to receive support after diagnosis and during treatment than those who lived with uncaring 
and unsupportive partners. The women in the current study who experienced support are indeed the 
lucky ones. 
4.5 SUMMARY 
The chapter provided for the discussion in detail, showing the problems women experience as 
physical problems, social-economic issues, pyscho-spiritual issues, sexual issues and healthy 
system challenges. 
In Chapter 5, the study will be justified, recommendations for future research will be made and the 
limitations of the study will be discussed. 
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CHAPTER 5 
JUSTIFICATION, LIMITATIONS AND RECOMMENDATIONS 
5.1 Introduction 
In the previous chapter, the findings of the enquiry were presented and discussed in detail. This 
chapter provides justification of the study, limitations to the study and recommendations. The focus 
of this study was to justify the study in terms of the research purpose. The focus is further to 
evaluate the study in terms of positive contribution to the body of scientific knowledge and to 
discuss the limitations of the study. Finally, further research to be conducted will be presented as 
well as the conclusion of the study. 
5.2 Justification of the study 
The study will be justified in terms of purpose of the study, which was to explore how women 
diagnosed with cervical cancer and treated with radiotherapy at an academic hospital in 
Johannesburg experience the long term effects of the disease and treatment.  
In Chapter 3, the research method and design was described in detail and in Chapter 4, the findings 
were described and discussed. The problems women experience, have been discussed in terms of 
physical problems, social-economic issues, psycho-spiritual issues, sexual issues and healthy 
system challenges. It can therefore be stated that this study is justified in that the purpose has been 
achieved. 
5.3 Limitations of the study 
 Only women treated at the one academic hospital were included in the study and the 
participants were homogenous in that only one racial group participated, therefore the 
findings cannot be generalised to other racial groups. 
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 Only women who could speak and understand basic English were included in the study, 
therefore the findings cannot be generalised to other women who can only speak an 
indigenous language. 
 Findings cannot be generalised to women who had treatment for cervical cancer longer than 
12 months as only women who had completed treatment 12 months prior to the study were 
included in the study. 
 This was a qualitative study and no such study reflects the only true meaning as there could 
be more than one interpretation of the narratives. 
5.4 Recommendations   
This study provides several answers regarding long term problems women experience after 
radiotherapy for cervical cancer. It is recommended that nurse researchers and nurse clinicians in 
collaboration with the multi-professional team and cervical cancer survivors develop and test 
interventions to address the late side-effects of cervical cancer to improve the disease and treatment 
related outcomes of these women. 
Further studies can be done to investigate experiences of cervical cancer and its treatment in 
women longer than 12 months after treatment, the current study can also be used as point of 
departure to develop a questionnaire and follow up with a quantitative study in order to include 
more respondents. 
For clinical practice it could be recommended that patient education skills of nurses working with 
these patients be scaled up. Doctors and nurses could be made aware of patients’ needs regarding 
pain management and other mentioned challenges, thus patients should be treated holistically. 
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5.5 Conclusion  
This study has provided evidence that women experience various physical problems due to the 
long term effects of cervical cancer and its treatment. These physical problems have an influence 
on their social, economic, psychological and sexual lives. The women are affected financially as 
they are unable to work or do hard jobs as they tire easily and eventually are unable to take care of 
their families. Women are also affected negatively socially, as they do not freely move in public 
and even fear to visit their loved ones as its embarrassing when they have soiled themselves. 
Physical problems also influence their sexual lives, as they experience discomfort when having sex 
with their spouses leading to fear of having sex, loss of sexual desire and changes to their body 
image. However, good support from families and having a belief in God as all knowing is a source 
of strength, which influences these women positively. 
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APPENDIX A 
INFORMATION DOCUMENT 
Study title:  WOMEN’S EXPERIENCES OF LONG-TERM EFFECTS OF CERVICAL 
CANCER AND ITS TREATMENT 
Good day Madam 
My name is Sophai Ntinga and I am currently registered as a student at the University of the 
Witwatersrand in the Department of Nursing Education. I would like to conduct research on the 
long-term effects of cancer of the mouth of the womb, also known as cervical cancer and its 
treatment, to learn what women experience. Research is the process to learn the answer to a 
question. If we can answer this question, it will help nurses to care for patients in a better way. I am 
approaching you to help us find out what women experience, as you had treatment with the 
machine (radiotherapy) for this illness (cancer of the mouth of the womb). This is not part of the 
routine care but will help us answer the above question. 
I would like to invite you to consider participating in this research study. For this study, I will use 
the words that people tell me and should you agree to take part in the study, I will interview you for 
about an hour. I will ask you about your experience since the completion of your radiotherapy 
treatment. With your permission and signing of a consent form, I will make a tape recording of our 
discussion. Only a few women (about 16) will take part in the study and the interviews will take 
place in the Radiation Oncology Department in a quiet and private room. 
You might become emotional during the interview, as you will be relating your experiences now 
that you have completed your treatment. Should you become emotional and not wish to continue.  I 
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will stop and reschedule the interview. With your permission, I will ask Sr Lucy Nqubezelo who 
works in the clinic to counsel you, her contact number is 011-488 2047.  
There are no direct benefits to you as the participant, however, the findings will assist nurses to 
identify and manage patient problems based on their needs. You can decide whether you would 
like to take part in the study or not, you will not lose any benefits to which you are entitled. If you 
decide to take part in the study, but decide to withdraw at any time during or immediately after the 
interview, you may do so without loss of any benefits to which you are entitled. However, once our 
interview has been typed, I will not be able to identify your interview as all names are removed, 
which means you will be unable to withdraw from the study. Please note that you will not receive 
any money or goods should you choose to take part in the study. 
I will keep information confidential.  Personal information may be made known if the law requests, 
research records may be inspected to view the quality and the Research Ethics Committee can 
inspect how I analysed what you told me. On completion of information analysis, all data sheets 
and the flash disk will be sealed in an envelope and placed in a safe in the Department of Nursing 
Education for a period of three years after publication of the report, where after it will be 
destroyed. When I write the report on what all the women told me, you might recognise your 
words, however people who will read the report will not be able to identify them. 
If you need further information about the study, please contact me, via my phone number, 
0732358835. 
 If you would like more information about the ethical permission of the study, or would like to 
report or complain about how the study was done, please contact Prof Peter Cleaton-Jones, on 011 
717 2301 during office hours or by e-mail at Peter.Cleaton-Jones@wits.ac.za. 
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Thank you for taking the time to read this information sheet. 
Yours sincerely,  
Sophai Ntinga 
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 APPENDIX B 
CONSENT FORM 
I have been given the information sheet on the Research Title: “Women’s experiences of long-
term effects of cervical cancer and its treatment”. I have read and understood the information 
sheet. If I agree to participate in the study, I will be interviewed for approximately 45 minutes to 
one hour about my experience since the completion of cervical cancer treatment and the disease.  
I understand  it is up to me whether or not  to participate in the interview and that there will be no  
penalty or loss of benefits to which  Iam entitled if I decide not to participate. I also understand that 
I may discontinue participation at any time until the interview has been typed without any penalty 
or loss of benefits to which am otherwise entitled. 
 I understand that the researcher involved in this study will make every effort to ensure 
confidentiality and my name will not be used in the study reports. No identifying information will 
be included when the interview is transcribed. I have been given the contact details that I may call 
if I have any questions or concerns about the research.  
This study has been explained to me. I have read and understand this consent form, I agree 
voluntarily to participate in the interview for this study. 
…………………………………… (Signature of participant)      ……………………. (Date) 
    
…………………………………… (Signature of researcher)      …………………….. (Date)                                            
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APPENDIX C 
CONSENT FORM FOR RECORDING INTERVIEW 
I have been given the information document on the Research Title: “Women’s experience of long-
term effects of cervical cancer and its treatment”. I have read and understood the information 
document. 
I understand that I can decide if the interview should be recorded and there will be no penalty or 
loss of benefits to which I am entitled if I decide against the recording. I also understand that I may 
discontinue participation at any time without any penalty or loss of benefits of which am otherwise 
entitled.  
I understand that information from the recording will be transcribed and transcripts will be given a 
code and my name will not be mentioned. I understand that I can ask the person interviewing me to 
stop recording, and to stop the interview altogether, at any time. 
I consent voluntarily for the researcher to record the interview. 
…………………………………… (Signature of participant)      ………………….. (Date) 
…………………………………… (Signature of researcher)       ………………….. (Date)                         
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        APPENDIX D 
                                           INTERVIEW GUIDE 
1. Age-  
2. Cultural group- 
3. Where living  
Urban  Rural  Other  
4. Marital status 
Married  Single  Widow  Divorced  Other  
5. Living arrangement  
With 
Husband 
 With 
Partner 
 With 
adult 
children 
 With 
young 
children 
 Other  
6. Personal monthly income 
7. How many people depend on this income? 
8. Do you take care of anybody?                            If yes, who? 
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9. Stage of the disease -  
10. Treatment  
External 
beam 
radiation 
 Brachytherapy  Chemotherapy  Other  
 
Interview questions    
Opening question: Please tell me what problems caused by the treatment you received for the 
cancer, are you experiencing at this stage? 
• Physical problems 
• Psychosocial 
• Other 
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   APPENDIX E 
                                                                                         University of the Witwatersrand 
                                                                                                  Faculty of Health Sciences   
                                                                                        Department of Nursing Education 
                                                                                                                          7 York Road 
                                                                                                                      Parktown   2193 
                  
The Chief Executive Officer, the Nursing Manager and the Unit Manager 
Charlotte Maxeke Johannesburg Academic Hospital 
Parktown 2193 
Johannesburg 
Dear Sir/Madam, 
RE: PERMISSION TO CONDUCT RESEARCH AT THE ONCOLOGY DEPARTMENT 
My name is Sophai Ntinga, a student at the University of the Witwatersrand, Johannesburg, 
currently registered for Master of Science in Nursing Oncology in the Department of Nursing 
Education. I am hereby asking for permission to undertake a research study at the Johannesburg 
Academic Hospital. I am investigating, “Women’s experiences of long-term effects of cervical 
cancer and its treatment”. 
The purpose of this study is to explore critically the experiences of women who have been treated 
with radiotherapy for cervical cancer after 12 months of treatment. This study will contribute to the 
provision of holistic care to the women in the follow up period post treatment for the cancer of the 
cervix. 
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Participation to this study is voluntary and confidential. The participants’ name will not appear 
anywhere and only code numbers will be used. The interviews will be conducted in a quiet and 
private room for approximately one hour. The information will be used for the intended purpose 
only. The participants are free to withdraw from the study at any time if they so wish without any 
negative consequence to their care. An informed written consent will be obtained from all patients 
to be included in the study. Patient signing of the consent will indicate acceptance to participate in 
the study. A tape recorder will be used during data collection and permission will be sought. 
Participants will be free to reject the audio-tape if they so wish. I hope to conduct this study in the 
Oncology department where women come for their follow-up care after radiotherapy treatment. 
The name of the participating Hospital and patients involved will not be divulged in the research 
report. Ethical clearance has been sought from the Human Research Ethics Committee of the 
University of the Witwatersrand. Please find the attached copy of my research proposal. 
Thanking you in anticipation for allowing me to conduct the study. Your permission is valuable 
and highly appreciated. 
Yours faithfully 
Sophai Ntinga (MSc Nursing Student) 
Date……………………………………….. 
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     APPENDIX F 
 
ETHICAL CLEARANCE CERTIFICATE 
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 APPENDIX G 
 
PERMISSION TO CONDUCT RESEARCH 
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